We also measured the plasma CSF2 levels in patients with stable coronary artery disease (non-MI participants) and patients who successfully underwent percutaneous coronary intervention operations (reperfusion therapy) after acute MI (MI/R patients). This evidence concerns the gene CSF2 and coronary artery disorder.